Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisatracurium for Prevention of Succinylcholine-Induced Fasciculation
NCT05760976Unknown
- Sponsor
- Yangzhou University
- Start
- Feb 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cisatracurium in fasciculation (3 arms), sponsored by Yangzhou University. Primary endpoints: Appearance of fasciculation at 2 minutes and Levels of fasciculation at 2 minutes. Status: unknown.
02
Drugs
cisatracurium
03
Conditions
fasciculation
Beyond the preview
Go deeper on NCT05760976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05760976.